Abstract
Development of resistance to ivermectinin vitro is reported for the first time. Two strains ofCaenorhabditis elegans D5 and D6 able to grow on agar plates after treating with up to 3 mg ivermectin per L were selected. The parent strain N2 was extremely sensitive to ivermectin, its growth being inhibited by treatment with 0.1–0.2 mg IVM per L.
Similar content being viewed by others
Abbreviations
- GABA:
-
4-aminobutyric acid
- IVM:
-
ivermectin
References
Brenner S.: The genetics ofCaemorhabditis elegans.Genetics 77, 71–94 (1974).
Campbell W.C.: Ivermectin: An update.Parasit.Today 1, 10–16 (1985).
Campbell W.C.:Ivermectin and abamectin. Springer-Verlag, New York — Berlin — Heidelberg — London — Paris —Tokyo 1989.
Novák J., Cimburková E., Vaněk Z.: A rapid screening ofS. avermitilis production strains.Biotechnol. Techn. 2, 47–52 (1988).
Ōmura S.: Philosophy of new drugs discovery.Microbiol.Rev. 50, 259–279 (1986).
Shoop W.L., Egerton J.R., Eary C.H., Suhayda D.: Laboratory selection of a benzimidazole-resistant isolate ofTrichostrongylus colubriformis for ivermectin resistance.J.Parasitol. 76, 186–189 (1990).
Simpkin K.G., Coles G.C.: The use ofCaenorhabditis elegans for anthelmintic screening.J.Chem.Technol.Biotechnol. 31, 66–69 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Novák, J., Vaněk, Z. Screening for a new generation of anthelminthic compounds.In vitro selection of the nematodeCaenorhabditis elegans for ivermectin resistance. Folia Microbiol 37, 237–238 (1992). https://doi.org/10.1007/BF02933156
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02933156